- Last Updated: 11/22/2011
Originally introduced to control blood sugar levels in type 2 diabetics, metformin in more recent years grabbed ALS researchers’ attention due to its ability to combat inflammation. Metformin is also being developed as a treatment for Huntington’s disease and multiple sclerosis.
- Last Updated: 7/12/2012
MoNuDin may protect motor neurons from dying by boosting their supplies of the neuroprotectant vascular endothelial growth factor (VEGF). A lentiviral-based vector, MoNuDin-delivered VEGF delays disease onset and slows progression in rodents with an ALS-like disease.
Find this useful?
Help us fund more science:
Hot Topics in Research
A pain reliever for pALS?
The DPS: helping PALS breathe better?
An early treatment for ALS?
What's next after dex?
Could MRI get PALS into trials sooner?
Neuralstem:safe & tolerable?
Exercise: good for PALS?
Why is creating ALS drugs so hard?